Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Jeanne Lumadue

Anatomic Pathology & Clinical Pathology State College, PA Medical Doctor

NPI 1376525055 CMS profile 715917

Centre Medical And Surgical Associates, P.C., 1850 East Park Avenue, Suite 205, State College, PA 16803

Open in the dashboard

General payments

$217,659

92 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Jeanne Lumadue of State College, PA is reported in the CMS Open Payments database as having received $217,659 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $21,067 8
2023 General $26,045 13
2022 General $65,119 21
2021 General $39,112 16
2020 General $37,224 20
2019 General $29,092 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeanne Lumadue
  • Anatomic Pathology & Clinical Pathology median
  • Middle half of Anatomic Pathology & Clinical Pathology
  • National median

In program year 2025, general payments to Jeanne Lumadue were reported at $0. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.

Show as a table
Year Jeanne Lumadue Anatomic Pathology & Clinical Pathology median Middle half National median
2019 $29,092 $65 $22–$150 $163
2020 $37,224 $44 $19–$144 $114
2021 $39,112 $42 $19–$142 $132
2022 $65,119 $54 $20–$140 $149
2023 $26,045 $60 $23–$157 $160
2024 $21,067 $51 $23–$145 $164
2025 $0 $51 $24–$149 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Takeda Pharmaceuticals U.S.A., Inc. $188,567 78 payments
  2. Shire North American Group Inc $29,092 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $214,652 87 payments
  2. Education $1,534 1 payment
  3. Travel and Lodging $886 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $580 1 payment
  5. Food and Beverage $7 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

769

Median for Pathology: 39

Drug cost

$139,147

Median for Pathology: $2,261

Branded share of claims

27.3%

Median for Pathology: 4.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 91 $92,366
Xarelto Rivaroxaban Brand 28 $34,325
Warfarin Sodium Generic 527 $7,410
Enoxaparin Sodium Generic 32 $3,827
Jantoven Warfarin Sodium Brand 91 $1,220

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 205 Part D prescribers listed as Pathology; they describe a distribution and say nothing about conduct.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology & Clinical Pathology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record